Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
UNH	UNITEDHEALTH GROUP INC	$261.87B	18.60%	5.70%	12.74%	21.70%	2.19	0.82	19.70%	4.00%	5.85%
PLX	PROTALIX BIOTHERAPEUTICS INC	$239.66M	11.30%	7.00%	12.37%	18.00%	0.56	3.03	57.50%	8.70%	12.06%
NTHI	NEONC TECHNOLOGIES HOLDINGS INC	$180.33M	N/A	N/A	N/A	N/A	-1.35	0.19	N/A	N/A	N/A
NVS	NOVARTIS AG	$317.08B	32.70%	13.20%	20.93%	39.00%	1.40	1.12	75.80%	24.70%	30.90%
MASS	908 DEVICES INC	$244.66M	-3.00%	-2.20%	-2.75%	-7.00%	0.40	3.49	49.20%	-7.20%	-7.12%
XOMA	XOMA ROYALTY CORP	$303.01M	20.30%	7.20%	10.39%	12.10%	1.77	3.91	100.00%	35.20%	51.78%
CTOR	CITIUS ONCOLOGY INC	$104.16M	-55.20%	-24.00%	-34.19%	-44.40%	0.88	0.83	80.00%	-599.30%	-565.79%
CSTL	CASTLE BIOSCIENCES INC	$975.48M	-2.70%	-2.30%	-3.70%	-5.70%	0.21	6.47	79.90%	-3.60%	-5.46%
USPH	U S PHYSICAL THERAPY INC	$1.32B	9.00%	3.80%	6.82%	15.50%	0.82	1.20	18.70%	5.90%	9.71%
HROW	HARROW INC	$1.87B	-9.00%	-1.40%	6.67%	9.40%	6.73	2.72	74.60%	-2.00%	7.95%
CGEN	COMPUGEN LTD	$157.14M	-53.60%	-25.40%	-35.53%	-123.40%	1.23	4.38	7.40%	-400.10%	-399.26%
ZNTL	ZENTALIS PHARMACEUTICALS INC	$170.51M	-51.50%	-40.00%	-51.54%	-45.80%	0.29	7.76	100.00%	368.10%	368.64%
ARDX	ARDELYX INC	$1.64B	-36.90%	-12.60%	-9.25%	-7.50%	2.15	4.41	88.20%	-14.20%	-9.35%
ALDX	ALDEYRA THERAPEUTICS INC	$309.84M	-72.20%	-47.90%	-83.73%	-130.90%	0.58	2.72	N/A	N/A	N/A
ERAS	ERASCA INC	$3.53B	-33.10%	-27.80%	-32.60%	-31.00%	0.21	10.45	N/A	N/A	N/A
PRVA	PRIVIA HEALTH GROUP INC	$2.72B	2.70%	1.50%	4.20%	-279.10%	0.83	1.67	10.20%	0.90%	1.58%
OFIX	ORTHOFIX MEDICAL INC	$534.60M	-25.60%	-14.10%	-13.42%	-17.40%	0.88	2.47	68.30%	-14.60%	-11.03%
LYEL	LYELL IMMUNOPHARMA INC	$538.52M	-96.70%	-76.00%	-86.59%	-101.30%	0.24	10.30	100.00%	-957,823.50%	-957,823.53%
CBLL	CERIBELL INC	$730.41M	-29.60%	-24.80%	-27.41%	-43.40%	0.22	12.65	88.00%	-63.30%	-61.02%
DAWN	DAY ONE BIOPHARMACEUTICALS INC	$1.22B	-32.10%	-28.20%	-31.77%	-35.90%	0.14	8.68	89.40%	-113.50%	-108.69%
SLN	SILENCE THERAPEUTICS PLC	$236.41M	N/A	-38.10%	-52.83%	-97.50%	-0.98	7.69	90.50%	-255.10%	-261.96%
OMDA	OMADA HEALTH INC	$663.63M	N/A	N/A	N/A	N/A	0.32	3.64	N/A	N/A	N/A
ARDT	ARDENT HEALTH INC	$1.40B	17.10%	4.10%	7.74%	6.70%	2.85	2.08	18.40%	3.20%	5.15%
EDAP	EDAP TMS SA	$174.46M	-62.10%	-27.00%	-64.33%	-74.90%	1.64	1.41	43.20%	-30.80%	-30.31%
EKSO	EKSO BIONICS HOLDINGS INC	$29.26M	-90.70%	-42.20%	-80.33%	-86.10%	1.24	1.66	53.50%	-70.70%	-69.29%
LMRI	LUMEXA IMAGING HOLDINGS INC	N/A	N/A	N/A	N/A	N/A	9.11	0.92	N/A	N/A	N/A
NNNN	ANBIO BIOTECHNOLOGY	$3.38B	11.20%	11.00%	9.34%	17.00%	0.01	211.10	89.70%	37.20%	37.20%
PRE	PRENETICS GLOBAL LTD	$302.09M	-28.90%	-22.90%	-31.52%	-46.70%	0.22	1.51	46.90%	-70.20%	-81.39%
LNSR	LENSAR INC	$139.27M	N/A	-73.70%	-149.46%	-190.00%	-3.18	1.24	46.10%	-87.10%	-87.14%
NRSN	NEUROSENSE THERAPEUTICS LTD	$24.60M	N/A	-491.20%	1,710.60%	441.30%	-4.25	0.71	N/A	N/A	N/A
SLGL	SOL-GEL TECHNOLOGIES LTD	$205.59M	N/A	N/A	N/A	N/A	0.33	5.15	N/A	N/A	N/A
SIGA	SIGA TECHNOLOGIES INC	$485.52M	35.30%	31.10%	46.88%	213.10%	0.14	9.17	76.30%	43.20%	56.27%
HRTX	HERON THERAPEUTICS INC	$218.20M	N/A	-5.70%	-6.97%	-4.50%	15.73	2.56	73.90%	-8.80%	-7.15%
RDNT	RADNET INC	$5.48B	-1.30%	-0.40%	2.01%	2.00%	2.22	1.88	11.40%	-0.60%	3.15%
QDEL	QUIDELORTHO CORP	$1.57B	-43.60%	-18.90%	-19.75%	-20.80%	1.79	1.78	47.20%	-43.50%	-35.70%
KZIA	KAZIA THERAPEUTICS LTD	$43.22M	N/A	-149.80%	280.88%	186.80%	-1.73	0.35	100.00%	-1,131.90%	-1,227.34%
JANX	JANUX THERAPEUTICS INC	$794.55M	-10.20%	-9.80%	-10.22%	-11.40%	0.05	35.86	100.00%	-1,019.00%	-1,018.95%
INGN	INOGEN INC	$154.47M	-13.20%	-8.30%	-10.78%	-25.80%	0.56	3.14	44.80%	-7.30%	-7.52%
RGC	REGENCELL BIOSCIENCE HOLDINGS LTD	$15.61B	-54.80%	-50.50%	-70.39%	-83.50%	0.18	7.39	N/A	N/A	N/A
CORT	CORCEPT THERAPEUTICS INC	$4.17B	15.90%	12.60%	9.84%	11.20%	0.30	3.14	98.20%	14.10%	8.65%
BDSX	BIODESIX INC	$101.67M	-504.40%	-43.90%	-45.53%	-31.60%	-52.52	1.84	79.80%	-49.30%	-40.07%
SPOK	SPOK HOLDINGS INC	$282.81M	11.00%	7.90%	13.77%	44.10%	0.41	1.21	79.30%	11.90%	15.82%
PTN	PALATIN TECHNOLOGIES INC	$31.17M	-5,515.10%	-114.80%	-82.96%	202.50%	0.56	2.76	100.00%	-107.40%	-107.32%
GERN	GERON CORP	$1.15B	-30.30%	-14.00%	-9.57%	-6.90%	1.28	5.96	97.70%	-43.60%	-25.04%
PACB	PACIFIC BIOSCIENCES OF CALIFORNIA INC	$477.01M	-289.50%	-53.70%	-66.93%	-45.80%	21.25	6.24	25.40%	-325.80%	-320.36%
CNTB	CONNECT BIOPHARMA HOLDINGS LTD	$158.77M	N/A	N/A	N/A	N/A	0.22	5.48	N/A	N/A	N/A
MDLN	MEDLINE INC	N/A	N/A	N/A	N/A	N/A	1.18	3.66	N/A	N/A	N/A
QTTB	Q32 BIO INC	$52.66M	N/A	-57.00%	-90.15%	-269.00%	-4.13	4.57	N/A	N/A	N/A
TDOC	TELADOC HEALTH INC	$809.28M	-15.60%	-7.00%	-9.24%	-19.60%	1.07	2.70	69.80%	-8.80%	-9.04%
PVLA	PALVELLA THERAPEUTICS INC	$947.98M	-68.50%	-45.50%	-49.43%	433.60%	0.73	6.49	100.00%	66,162.30%	52,807.55%
ABUS	ARBUTUS BIOPHARMA CORP	$801.99M	-50.20%	-37.60%	-45.57%	-57.70%	0.26	18.80	100.00%	-289.40%	-288.70%
GLTO	GALECTO INC	$39.70M	-130.70%	-111.30%	-195.32%	-1,211.70%	0.34	3.73	N/A	N/A	N/A
RLAY	RELAY THERAPEUTICS INC	$1.59B	-42.90%	-38.80%	-46.69%	-45.00%	0.10	19.14	100.00%	-3,561.40%	-3,561.43%
PBH	PRESTIGE CONSUMER HEALTHCARE INC	$3.14B	10.20%	5.40%	9.19%	21.60%	0.91	3.11	56.10%	16.90%	27.94%
PHAT	PHATHOM PHARMACEUTICALS INC	$907.73M	N/A	-94.40%	-138.80%	-37.00%	-1.57	2.23	87.20%	-186.50%	-138.77%
SGRY	SURGERY PARTNERS INC	$2.02B	-9.80%	-2.20%	2.88%	3.70%	2.78	1.88	23.90%	-5.20%	6.44%
SEER	SEER INC	$114.37M	-26.50%	-23.60%	-26.94%	-26.10%	0.14	14.25	50.70%	-484.50%	-482.85%
MRNA	MODERNA INC	$17.16B	-31.40%	-24.40%	-30.16%	-30.90%	0.30	3.93	48.30%	-139.60%	-141.26%
OSCR	OSCAR HEALTH INC	$3.99B	-39.50%	-7.30%	-28.71%	105.20%	5.47	0.95	14.40%	-3.80%	-3.59%
MYNZ	MAINZ BIOMED NV	$2.76M	N/A	-207.80%	-508.89%	-2,883.90%	2.89	0.52	67.50%	-2,874.70%	-2,942.01%
BFLY	BUTTERFLY NETWORK INC	$767.91M	-37.80%	-27.10%	-32.76%	-62.80%	0.42	4.80	43.20%	-90.30%	-88.76%
NXTC	NEXTCURE INC	$35.40M	-132.90%	-98.60%	-202.71%	-149.10%	0.68	2.97	N/A	N/A	N/A
BDX	BECTON DICKINSON & CO	$50.51B	6.90%	3.20%	5.60%	8.90%	1.17	1.05	46.10%	8.00%	11.77%
HYFT	MINDWALK HOLDINGS CORP	$63.70M	-136.90%	-76.10%	-155.54%	-149.70%	0.47	4.19	58.50%	-146.10%	-159.30%
CAMP	CAMP4 THERAPEUTICS CORP	$190.34M	-100.10%	-76.60%	-68.03%	-490.20%	0.47	9.83	100.00%	-1,404.50%	-1,404.47%
IONS	IONIS PHARMACEUTICALS INC	$13.18B	-44.30%	-8.70%	-7.89%	-4.80%	3.91	2.79	98.80%	-26.50%	-17.37%
RLMD	RELMADA THERAPEUTICS INC	$266.93M	-269.50%	-205.20%	-579.92%	-296.10%	0.57	2.86	N/A	N/A	N/A
UNCY	UNICYCIVE THERAPEUTICS INC	$133.68M	-184.40%	-95.50%	-89.14%	368.10%	0.35	3.83	N/A	N/A	N/A
NVCR	NOVOCURE LTD	$1.25B	-50.30%	-13.90%	-30.20%	-17.00%	2.99	1.55	75.40%	-27.70%	-27.51%
SLS	SELLAS LIFE SCIENCES GROUP INC	$521.34M	-95.20%	-75.10%	-56.85%	1,520.90%	0.13	8.28	N/A	N/A	N/A
INSM	INSMED INC	$32.10B	-183.60%	-54.60%	-56.31%	-53.90%	1.50	4.63	76.50%	-264.80%	-244.81%
CRVS	CORVUS PHARMACEUTICALS INC	$1.31B	-25.80%	-20.20%	-20.82%	-28.70%	0.12	8.29	N/A	N/A	N/A
BBIO	BRIDGEBIO PHARMA INC	$14.62B	N/A	-82.20%	-86.24%	-30.80%	-1.51	3.88	95.80%	-225.30%	-190.53%
TCRX	TSCAN THERAPEUTICS INC	$55.33M	-73.90%	-45.10%	-59.97%	-67.10%	0.82	6.44	100.00%	-1,693.00%	-1,659.11%
NVO	NOVO NORDISK A S	$220.44B	61.10%	20.20%	39.89%	51.50%	1.80	0.80	81.00%	33.10%	42.24%
KPTI	KARYOPHARM THERAPEUTICS INC	$172.43M	N/A	-179.30%	-917.99%	-86.00%	-1.37	1.12	95.90%	-134.20%	-102.79%
PLRZ	POLYRIZON LTD	$13.62M	-12.40%	-11.70%	-18.72%	-3,440.00%	0.02	44.04	N/A	N/A	N/A
AKTS	AKTIS ONCOLOGY INC	N/A	N/A	N/A	N/A	N/A	-0.59	9.27	N/A	N/A	N/A
SGP	SPYGLASS PHARMA INC	N/A	N/A	N/A	N/A	N/A	-0.11	18.11	N/A	N/A	N/A
HYPD	HYPERION DEFI INC	$30.69M	-123.80%	-71.30%	-30.02%	-78.70%	0.17	2.25	-798.10%	-7,643.90%	-6,846.13%
ONMD	ONEMEDNET CORP	$31.32M	N/A	-87.50%	55.64%	34.20%	-1.38	0.29	-144.00%	-411.10%	-393.33%
ACOG	ALPHA COGNITION INC	$113.28M	-52.60%	-40.80%	-50.11%	-1,606.00%	0.37	6.69	73.10%	-262.20%	-266.30%
ACH	ACCENDRA HEALTH INC	$180.99M	-1,259.50%	-30.30%	-78.24%	-44.10%	-10.40	0.86	26.10%	-20.00%	-18.32%
PROF	PROFOUND MEDICAL CORP	$201.69M	-96.60%	-79.10%	-137.14%	-335.10%	0.32	4.18	71.80%	-318.90%	-321.05%
BRKR	BRUKER CORP	$5.79B	-1.20%	-0.40%	0.61%	0.70%	1.64	1.85	47.20%	-0.70%	0.91%
PBM	PSYENCE BIOMEDICAL LTD	$835.68k	N/A	N/A	N/A	N/A	0.08	8.09	N/A	N/A	N/A
PASG	PASSAGE BIO INC	$28.02M	-102.10%	-53.00%	-87.19%	-120.00%	1.38	2.51	N/A	N/A	N/A
CTXR	CITIUS PHARMACEUTICALS INC	$16.60M	-52.50%	-27.60%	-33.67%	-48.00%	0.59	0.99	80.00%	-909.90%	-872.34%
TEM	TEMPUS AI INC	$9.35B	-68.00%	-12.80%	-9.38%	-15.10%	3.49	3.28	61.70%	-18.40%	-16.39%
LEGN	LEGEND BIOTECH CORP	$3.34B	-23.40%	-14.30%	-15.74%	-27.80%	0.69	2.87	60.60%	-26.40%	-22.16%
IVVD	INVIVYD INC	$361.34M	-93.00%	-51.90%	-63.24%	-758.30%	0.50	2.47	93.30%	-119.60%	-119.63%
XLO	XILIO THERAPEUTICS INC	$29.24M	-857.90%	-52.90%	-75.67%	265.00%	-17.52	2.20	100.00%	-183.90%	-183.90%
POAS	PHAOS TECHNOLOGY (CAYMAN) HOLDINGS LTD	N/A	-1,073.10%	-144.30%	275.47%	9,727.00%	-1.99	0.40	22.10%	-3,063.10%	-3,058.07%
CYPH	CYPHERPUNK TECHNOLOGIES INC	$41.30M	-316.10%	-176.10%	-1,881.63%	435.00%	3.23	1.21	N/A	N/A	N/A
HCAT	HEALTH CATALYST INC	$122.36M	-30.30%	-14.60%	-18.48%	-35.40%	0.77	1.88	46.50%	-34.10%	-29.19%
GRCE	GRACE THERAPEUTICS INC	$60.97M	-9.30%	-8.60%	-10.41%	602.20%	0.06	14.96	N/A	N/A	N/A
MANE	VERADERMICS INC	N/A	N/A	N/A	N/A	N/A	-0.06	3.29	N/A	N/A	N/A
LXEO	LEXEO THERAPEUTICS INC	$458.36M	-90.50%	-70.90%	-82.85%	-112.40%	0.19	7.40	N/A	N/A	N/A
AVXL	ANAVEX LIFE SCIENCES CORP	$374.39M	-38.80%	-35.00%	-31.54%	408.90%	0.05	20.87	N/A	N/A	N/A
CNTA	CENTESSA PHARMACEUTICALS PLC	$3.35B	-67.70%	-47.50%	-54.43%	-51.00%	0.49	10.57	100.00%	-1,618.00%	-1,521.18%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	610	+1.46%	+0.32%	-0.48%	-29.81%	203.20x	5.16x	-23.77%	-9.51%	-6.53%	+67.37%	Strong Buy
Diagnostics & Research	56	-0.40%	-4.39%	-12.07%	+6.08%	16.70x	3.97x	-4.44%	+6.36%	+11.82%	+22.58%	Buy
Drug Manufacturers - General	20	+0.36%	+2.68%	+8.12%	+28.89%	43.99x	7.33x	+100.80%	+12.44%	+21.08%	+4.47%	Buy
Drug Manufacturers - Specialty & Generic	75	+1.04%	-0.27%	+0.71%	-27.50%	-166.20x	1.75x	+9.97%	+2.28%	+5.20%	+42.63%	Buy
Healthcare Plans	10	-0.35%	+4.19%	-12.63%	-24.67%	19.38x	1.91x	+11.67%	+3.66%	+8.52%	+20.65%	Buy
Health Information Services	54	+0.76%	-3.56%	-18.69%	-91.47%	27.39x	3.20x	+8.66%	+4.39%	+6.53%	+66.23%	Buy
Medical Care Facilities	50	-0.09%	+5.82%	+12.69%	-30.49%	16.89x	5.91x	-68.69%	+7.69%	+15.92%	+10.21%	Buy
Medical Devices	139	+1.82%	-1.81%	-5.06%	-84.07%	21.83x	3.65x	+11.89%	+7.22%	+9.67%	+41.83%	Strong Buy
Medical Distribution	10	+0.90%	+0.77%	+10.03%	+52.80%	32.39x	277.72x	-98.61%	+3.54%	+23.66%	+2.69%	Buy
Medical Instruments & Supplies	57	+0.57%	-0.94%	-3.87%	-14.92%	171.28x	3.06x	+9.60%	+8.37%	+10.83%	+23.32%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Feb 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Pediatrix Medical Group (NYSE:MD)

Pediatrix Medical Group (NYSE:MD) is the #1 top healthcare stock out of 1081 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pediatrix Medical Group (NYSE:MD) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: B, Financials: B, and AI: C.

Pediatrix Medical Group (NYSE:MD) has a Due Diligence Score of 44, which is 18 points higher than the healthcare sector average of 26. It passed 14 out of 33 due diligence checks and has strong fundamentals. Pediatrix Medical Group has seen its stock return 51.92% over the past year, overperforming other healthcare stocks by 105 percentage points.

Pediatrix Medical Group has an average 1 year price target of $21.33, a downside of -1.74% from Pediatrix Medical Group's current stock price of $21.71.

Pediatrix Medical Group stock has a consensus Hold recommendation according to Wall Street analysts. Of the 3 analysts covering Pediatrix Medical Group, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #2 top healthcare stock out of 1081 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: A, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 30, which is 4 points higher than the healthcare sector average of 26. It passed 10 out of 33 due diligence checks and has average fundamentals. Bioventus has seen its stock lose -19.35% over the past year, overperforming other healthcare stocks by 33 percentage points.

Bioventus has an average 1 year price target of $13.00, an upside of 55.13% from Bioventus's current stock price of $8.38.

Bioventus stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Bioventus, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the #3 top healthcare stock out of 1081 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Ironwood Pharmaceuticals (NASDAQ:IRWD) is: Value: A, Growth: B, Momentum: B, Sentiment: C, Safety: C, Financials: A, and AI: C.

Ironwood Pharmaceuticals (NASDAQ:IRWD) has a Due Diligence Score of 40, which is 14 points higher than the healthcare sector average of 26. It passed 13 out of 33 due diligence checks and has average fundamentals. Ironwood Pharmaceuticals has seen its stock return 139% over the past year, overperforming other healthcare stocks by 192 percentage points.

Ironwood Pharmaceuticals has an average 1 year price target of $6.50, an upside of 35.98% from Ironwood Pharmaceuticals's current stock price of $4.78.

Ironwood Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Ironwood Pharmaceuticals, 0% have issued a Strong Buy rating, 50% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 68 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 29.06%, which is 27 percentage points higher than the healthcare sector average of 2.26%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

2. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 9.1%, which is 7 percentage points higher than the healthcare sector average of 2.26%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 154.3% indicates that its high dividend yield might not be sustainable for the long-term.

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 7.81%, which is 6 percentage points higher than the healthcare sector average of 2.26%.

Oramed Pharmaceuticals's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.81% in the last day, and down -0.2% over the last week. Polaryx Therapeutics was the among the top gainers in the healthcare sector, gaining 64.32% yesterday.

Polaryx shares are trading higher after the company announced it selected a contract research organization for SOTERIA to evaluate PLX-200, across four different LSDs.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 86, which is 68 points higher than the healthcare sector average of 18. It passed 6 out of 7 valuation due diligence checks.

Embecta's stock has dropped -32.88% in the past year. It has overperformed other stocks in the healthcare sector by 20 percentage points.

2. Nutex Health (NASDAQ:NUTX)

Nutex Health (NASDAQ:NUTX) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Nutex Health has a valuation score of 57, which is 39 points higher than the healthcare sector average of 18. It passed 4 out of 7 valuation due diligence checks.

Nutex Health's stock has gained 53.58% in the past year. It has overperformed other stocks in the healthcare sector by 106 percentage points.

3. Organon & Co (NYSE:OGN)

Organon & Co (NYSE:OGN) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Organon & Co has a valuation score of 71, which is 53 points higher than the healthcare sector average of 18. It passed 5 out of 7 valuation due diligence checks.

Organon & Co's stock has dropped -52.97% in the past year. It has performed in line with other stocks in the healthcare sector.

Are healthcare stocks a good buy now?

57.82% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 39.3% over the next year.

6.59% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.93% of healthcare stocks are rated B (Buy), 46.95% are rated C (Hold), 25.03% are rated D (Sell), and 8.5% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 59.51x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Pediatrix Medical Group (NYSE:MD)

2. Bioventus (NASDAQ:BVS)

3. Ironwood Pharmaceuticals (NASDAQ:IRWD)

1. Dominari Holdings (NASDAQ:DOMH)

2. Spok Holdings (NASDAQ:SPOK)

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

1. Embecta (NASDAQ:EMBC)

2. Nutex Health (NASDAQ:NUTX)

3. Organon & Co (NYSE:OGN)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Pediatrix Medical Group (NYSE:MD)

2. Bioventus (NASDAQ:BVS)

3. Ironwood Pharmaceuticals (NASDAQ:IRWD)

1. Dominari Holdings (NASDAQ:DOMH)

2. Spok Holdings (NASDAQ:SPOK)

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

1. Embecta (NASDAQ:EMBC)

2. Nutex Health (NASDAQ:NUTX)

3. Organon & Co (NYSE:OGN)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.